ANTX Earnings Date: Nov 5, 2026 (Estimated) — AN2 Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is ANTX's next earnings date?
AN2 Therapeutics, Inc. (ANTX) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20.
How did ANTX do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), AN2 Therapeutics, Inc. posted EPS of -$0.18 versus the -$0.24 estimate, a beat of 25.0%. Revenue was $0. The stock's 1-day post-earnings move was +7.0%.
How much does ANTX stock move after earnings?
ANTX beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.3% (up or down) in the day after earnings.
About AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was established in 2017 and operates from its headquarters situated in Menlo Park, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.24 | -0.18 | +25.00% | $0 | ✅ Beat | +6.98% | +1.70% | -3.07% |
| 2026-05-11 | Q1 2026 | -0.23 | -0.29 | -26.09% | $0 | ❌ Miss | -9.53% | -5.08% | -11.02% |
| 2026-03-17 | Q4 2025 | -0.24 | -0.29 | -20.83% | $0 | ❌ Miss | -7.60% | -24.60% | -37.20% |
| 2025-11-12 | Q3 2025 | -0.22 | -0.31 | -40.91% | $0 | ❌ Miss | -4.24% | -8.47% | +1.69% |
| 2025-08-12 | Q2 2025 | -0.31 | -0.21 | +32.26% | $0 | ✅ Beat | +0.00% | +9.52% | +20.95% |
| 2025-03-25 | Q4 2024 | -0.26 | -0.25 | +3.85% | $0 | ✅ Beat | +1.33% | -8.00% | -14.00% |
| 2024-11-13 | Q3 2024 | -0.54 | -0.43 | +20.37% | $0 | ✅ Beat | -0.99% | +28.71% | +41.58% |
| 2024-08-13 | Q2 2024 | -0.59 | -0.48 | +18.64% | $0 | ✅ Beat | -3.67% | -3.67% | -4.59% |
Showing last 8 quarters.